Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Mar 27, 2023; 15(3): 480-487
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.480
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.480
Time | April, 2020 | September, 2021 | January, 2021 | November, 2021 | December, 2021 | January, 2022 | February, 2022 | March, 2022 | April, 2022 | May, 2022 | June, 2022 | July, 2022 | August, 2022 | September, 2022 | |
Treatment | Admission | Suspend | 4 cycles of doxorubicin and carboplatin | 9 cycles of sindilizumb in combination with doxorubicin and carboplatin | |||||||||||
Temp/°C | 37.1 | NA | 36.2 | 37 | 36.5 | 36.8 | 36.5 | 36.3 | 37.1 | 36.8 | NA | 36.8 | 36.9 | 37.2 | 36.9 |
HR/min | 86 | NA | 76 | 84 | 75 | 79 | 82 | 78 | 82 | 81 | NA | 79 | 75 | 79 | 77 |
RR/min | 19 | NA | 19 | 18 | 19 | 19 | 19 | 18 | 19 | 17 | NA | 18 | 19 | 18 | 19 |
BP/kPa | 16.1/7.5 | NA | 15.4/8.5 | 18.7/9.7 | 18.4/11.1 | 16.9/11.9 | 16.5/9.3 | 16.5/9.7 | 16.0/9.5 | 14.0/8.4 | NA | 12.0/8.0 | 12.5/8.7 | 13.2/9.6 | 13.1/8.0 |
Weight/kg | 56 | NA | 49 | 51 | 51.5 | 52 | 53.8 | 52 | 51.3 | 50.9 | NA | 50.5 | 51 | 52.3 | 53 |
WBC/109/L | 5.11 | NA | 5.4 | 5.91 | 5.03 | 3.6 | 3.34 | 2.91 | 3.23 | 4.02 | NA | 4.42 | 4.51 | 4.43 | 4.52 |
Hb/g/L | 133 | NA | 124 | 114 | 105 | 96 | 102 | 102 | 106 | 109 | NA | 111 | 112 | 112 | 113 |
Alb/g/L | 39.9 | NA | 38.5 | 42 | 40.3 | 36.9 | 45.6 | NA | 44.2 | 43.4 | NA | 43.1 | 40.7 | 37.6 | 35.3 |
ALT/U/L | 34 | NA | 20 | 17 | 17 | 16 | 20 | 21 | 22 | 23 | NA | 24 | 36 | 47 | 54 |
AST/U/L | 29 | NA | 25 | 24 | 17 | 8.3 | 26 | NA | 27 | 28 | NA | 28 | 37 | 43 | 47 |
CEA/µg/L | 1 | NA | 0.8 | 1.2 | 1.1 | 0.9 | 1 | 0.8 | 0.9 | 0.8 | NA | 0.8 | 0.9 | 0.8 | 0.8 |
CA125/U/mL | 11.1 | NA | 14.4 | 19.3 | 14.6 | 8.9 | 10.2 | 10.3 | 9.7 | 9.1 | NA | 9 | 9.3 | 9.7 | 10.7 |
CA199/U/mL | 71.2 | NA | 146.8 | 151.5 | 153.6 | 154.3 | 160.8 | 37.8 | 32.6 | 29.8 | NA | 22.3 | 24.3 | 25.6 | 27.1 |
CA153/U/mL | 4.9 | NA | 5.6 | 11.1 | 9.4 | 7.3 | 8.4 | 9 | 6.1 | 5.2 | NA | 4.6 | 4.6 | 4.5 | 4.5 |
CA724/U/mL | 2.3 | NA | 2.7 | 5.7 | 8.5 | 14.3 | 1.5 | 5.6 | 3.4 | 3.8 | NA | 2.4 | 2.3 | 2.2 | 2.1 |
Time | Temp/°C | HR/min | RR/min | BP/kPa | Weight/kg | WBC/109/L | Hb/g/L | Alb/g/L | ALT/U/L | AST/U/L | CEA/µg/L | CA125/U/mL | CA199/U/mL | CA153/U/mL | CA724/U/mL |
January, 2022 | 36.5 | 92 | 17 | 14.2/9.6 | 44.7 | 5.99 | 118 | 43.1 | 19 | 17 | 2.8 | 32 | 23 | 13.6 | 18.3 |
November, 2022 | 37 | 87 | 19 | 14.7/10.4 | 45.2 | 6.45 | 115 | 35.8 | 18 | 23 | 2.3 | 31.7 | 24.6 | 15.6 | 19.3 |
- Citation: Hu XC, Gan CX, Zheng HM, Wu XP, Pan WS. Immunotherapy in combination with chemotherapy for Peutz-Jeghers syndrome with advanced cervical cancer: A case report. World J Gastrointest Surg 2023; 15(3): 480-487
- URL: https://www.wjgnet.com/1948-9366/full/v15/i3/480.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i3.480